nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—FYN—epilepsy syndrome	0.215	0.594	CbGaD
Dasatinib—SRC—epilepsy syndrome	0.0868	0.24	CbGaD
Dasatinib—ABCG2—epilepsy syndrome	0.0426	0.118	CbGaD
Dasatinib—CYP1B1—Propofol—epilepsy syndrome	0.0257	0.101	CbGbCtD
Dasatinib—CYP1B1—Phenobarbital—epilepsy syndrome	0.0246	0.0962	CbGbCtD
Dasatinib—ABCB1—epilepsy syndrome	0.0177	0.049	CbGaD
Dasatinib—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0129	0.0505	CbGbCtD
Dasatinib—CYP1A1—Propofol—epilepsy syndrome	0.0113	0.0442	CbGbCtD
Dasatinib—CYP1A1—Phenobarbital—epilepsy syndrome	0.0108	0.0422	CbGbCtD
Dasatinib—ABCB1—Levetiracetam—epilepsy syndrome	0.00917	0.0359	CbGbCtD
Dasatinib—CYP3A5—Carbamazepine—epilepsy syndrome	0.00809	0.0317	CbGbCtD
Dasatinib—CYP3A5—Phenytoin—epilepsy syndrome	0.00726	0.0284	CbGbCtD
Dasatinib—CYP3A5—Phenobarbital—epilepsy syndrome	0.00647	0.0253	CbGbCtD
Dasatinib—CYP3A5—Midazolam—epilepsy syndrome	0.00638	0.025	CbGbCtD
Dasatinib—ABCB1—Clobazam—epilepsy syndrome	0.00636	0.0249	CbGbCtD
Dasatinib—CYP3A5—Diazepam—epilepsy syndrome	0.00613	0.024	CbGbCtD
Dasatinib—ABCB1—Lamotrigine—epilepsy syndrome	0.00612	0.024	CbGbCtD
Dasatinib—CYP1A2—Carbamazepine—epilepsy syndrome	0.00602	0.0236	CbGbCtD
Dasatinib—CYP1A2—Primidone—epilepsy syndrome	0.00562	0.022	CbGbCtD
Dasatinib—ABCB1—Carbamazepine—epilepsy syndrome	0.00527	0.0206	CbGbCtD
Dasatinib—CYP1A2—Propofol—epilepsy syndrome	0.00504	0.0197	CbGbCtD
Dasatinib—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00503	0.0197	CbGbCtD
Dasatinib—CYP3A5—Valproic Acid—epilepsy syndrome	0.00484	0.0189	CbGbCtD
Dasatinib—CYP1A2—Phenobarbital—epilepsy syndrome	0.00482	0.0189	CbGbCtD
Dasatinib—ABCB1—Phenytoin—epilepsy syndrome	0.00473	0.0185	CbGbCtD
Dasatinib—CYP3A4—Trimethadione—epilepsy syndrome	0.00467	0.0183	CbGbCtD
Dasatinib—CYP3A4—Felbamate—epilepsy syndrome	0.00467	0.0183	CbGbCtD
Dasatinib—CYP1A2—Diazepam—epilepsy syndrome	0.00457	0.0179	CbGbCtD
Dasatinib—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00439	0.0172	CbGbCtD
Dasatinib—ABCB1—Phenobarbital—epilepsy syndrome	0.00421	0.0165	CbGbCtD
Dasatinib—ABCB1—Midazolam—epilepsy syndrome	0.00415	0.0163	CbGbCtD
Dasatinib—ABCB1—Diazepam—epilepsy syndrome	0.00399	0.0156	CbGbCtD
Dasatinib—CYP3A4—Clonazepam—epilepsy syndrome	0.00397	0.0156	CbGbCtD
Dasatinib—CYP3A4—Clobazam—epilepsy syndrome	0.00381	0.0149	CbGbCtD
Dasatinib—CYP1A2—Valproic Acid—epilepsy syndrome	0.0036	0.0141	CbGbCtD
Dasatinib—CYP3A4—Rufinamide—epilepsy syndrome	0.00324	0.0127	CbGbCtD
Dasatinib—CYP3A4—Carbamazepine—epilepsy syndrome	0.00316	0.0124	CbGbCtD
Dasatinib—CYP3A4—Primidone—epilepsy syndrome	0.00295	0.0115	CbGbCtD
Dasatinib—CYP3A4—Phenytoin—epilepsy syndrome	0.00283	0.0111	CbGbCtD
Dasatinib—CYP3A4—Propofol—epilepsy syndrome	0.00264	0.0103	CbGbCtD
Dasatinib—CYP3A4—Acetazolamide—epilepsy syndrome	0.00252	0.00988	CbGbCtD
Dasatinib—CYP3A4—Phenobarbital—epilepsy syndrome	0.00252	0.00988	CbGbCtD
Dasatinib—CYP3A4—Midazolam—epilepsy syndrome	0.00249	0.00975	CbGbCtD
Dasatinib—CYP3A4—Diazepam—epilepsy syndrome	0.00239	0.00937	CbGbCtD
Dasatinib—CYP3A4—Zonisamide—epilepsy syndrome	0.00233	0.00915	CbGbCtD
Dasatinib—CYP3A4—Valproic Acid—epilepsy syndrome	0.00189	0.00739	CbGbCtD
Dasatinib—CYP3A4—Topiramate—epilepsy syndrome	0.0017	0.00666	CbGbCtD
Dasatinib—TESK1—Loxapine—Clobazam—epilepsy syndrome	0.000656	0.345	CbGdCrCtD
Dasatinib—TESK1—Loxapine—Diazepam—epilepsy syndrome	0.00061	0.321	CbGdCrCtD
Dasatinib—ERBB3—Bortezomib—Lacosamide—epilepsy syndrome	0.000331	0.174	CbGdCrCtD
Dasatinib—CSK—Bortezomib—Lacosamide—epilepsy syndrome	0.000305	0.16	CbGdCrCtD
Dasatinib—CSK—spinal cord—epilepsy syndrome	0.000212	0.00279	CbGeAlD
Dasatinib—MAP3K19—nervous system—epilepsy syndrome	0.000212	0.00279	CbGeAlD
Dasatinib—BMPR1B—nervous system—epilepsy syndrome	0.000212	0.00279	CbGeAlD
Dasatinib—YES1—telencephalon—epilepsy syndrome	0.00021	0.00276	CbGeAlD
Dasatinib—HCK—spinal cord—epilepsy syndrome	0.00021	0.00276	CbGeAlD
Dasatinib—MAP2K5—brainstem—epilepsy syndrome	0.00021	0.00276	CbGeAlD
Dasatinib—EPHA5—central nervous system—epilepsy syndrome	0.000208	0.00274	CbGeAlD
Dasatinib—ZAK—cerebellum—epilepsy syndrome	0.000208	0.00274	CbGeAlD
Dasatinib—TNK2—nervous system—epilepsy syndrome	0.000208	0.00273	CbGeAlD
Dasatinib—LYN—central nervous system—epilepsy syndrome	0.000207	0.00272	CbGeAlD
Dasatinib—PDGFRA—telencephalon—epilepsy syndrome	0.000206	0.00271	CbGeAlD
Dasatinib—TESK1—head—epilepsy syndrome	0.000206	0.00271	CbGeAlD
Dasatinib—BMPR1B—central nervous system—epilepsy syndrome	0.000204	0.00268	CbGeAlD
Dasatinib—MAP3K19—central nervous system—epilepsy syndrome	0.000204	0.00268	CbGeAlD
Dasatinib—EPHA5—cerebellum—epilepsy syndrome	0.000203	0.00268	CbGeAlD
Dasatinib—EPHB3—head—epilepsy syndrome	0.000203	0.00267	CbGeAlD
Dasatinib—STK36—head—epilepsy syndrome	0.000203	0.00267	CbGeAlD
Dasatinib—SRC—telencephalon—epilepsy syndrome	0.000202	0.00266	CbGeAlD
Dasatinib—STAT5B—brain—epilepsy syndrome	0.000202	0.00266	CbGeAlD
Dasatinib—RIPK2—midbrain—epilepsy syndrome	0.000202	0.00266	CbGeAlD
Dasatinib—TNK2—central nervous system—epilepsy syndrome	0.0002	0.00263	CbGeAlD
Dasatinib—BMPR1B—cerebellum—epilepsy syndrome	0.000199	0.00262	CbGeAlD
Dasatinib—CSF1R—forebrain—epilepsy syndrome	0.000197	0.0026	CbGeAlD
Dasatinib—RIPK2—spinal cord—epilepsy syndrome	0.000197	0.00259	CbGeAlD
Dasatinib—LIMK2—head—epilepsy syndrome	0.000196	0.00258	CbGeAlD
Dasatinib—TNK2—cerebellum—epilepsy syndrome	0.000196	0.00257	CbGeAlD
Dasatinib—TESK1—nervous system—epilepsy syndrome	0.000195	0.00257	CbGeAlD
Dasatinib—ERBB3—midbrain—epilepsy syndrome	0.000193	0.00254	CbGeAlD
Dasatinib—SIK1—spinal cord—epilepsy syndrome	0.000192	0.00253	CbGeAlD
Dasatinib—STK36—nervous system—epilepsy syndrome	0.000192	0.00253	CbGeAlD
Dasatinib—EPHB3—nervous system—epilepsy syndrome	0.000192	0.00253	CbGeAlD
Dasatinib—STK35—head—epilepsy syndrome	0.00019	0.0025	CbGeAlD
Dasatinib—CSK—head—epilepsy syndrome	0.000189	0.00248	CbGeAlD
Dasatinib—ERBB3—spinal cord—epilepsy syndrome	0.000189	0.00248	CbGeAlD
Dasatinib—TESK1—central nervous system—epilepsy syndrome	0.000188	0.00247	CbGeAlD
Dasatinib—EPHB4—medulla oblongata—epilepsy syndrome	0.000187	0.00246	CbGeAlD
Dasatinib—EPHA3—brain—epilepsy syndrome	0.000187	0.00246	CbGeAlD
Dasatinib—HCK—head—epilepsy syndrome	0.000186	0.00245	CbGeAlD
Dasatinib—MAP2K5—telencephalon—epilepsy syndrome	0.000186	0.00245	CbGeAlD
Dasatinib—LIMK2—nervous system—epilepsy syndrome	0.000186	0.00244	CbGeAlD
Dasatinib—KIT—brainstem—epilepsy syndrome	0.000186	0.00244	CbGeAlD
Dasatinib—JAK2—medulla oblongata—epilepsy syndrome	0.000185	0.00244	CbGeAlD
Dasatinib—EPHB3—central nervous system—epilepsy syndrome	0.000185	0.00243	CbGeAlD
Dasatinib—STK36—central nervous system—epilepsy syndrome	0.000185	0.00243	CbGeAlD
Dasatinib—TESK1—cerebellum—epilepsy syndrome	0.000184	0.00242	CbGeAlD
Dasatinib—FYN—medulla oblongata—epilepsy syndrome	0.000183	0.00241	CbGeAlD
Dasatinib—SIK3—brain—epilepsy syndrome	0.000182	0.00239	CbGeAlD
Dasatinib—CSF1R—telencephalon—epilepsy syndrome	0.000181	0.00239	CbGeAlD
Dasatinib—STK36—cerebellum—epilepsy syndrome	0.000181	0.00238	CbGeAlD
Dasatinib—EPHB3—cerebellum—epilepsy syndrome	0.000181	0.00238	CbGeAlD
Dasatinib—STK35—nervous system—epilepsy syndrome	0.00018	0.00237	CbGeAlD
Dasatinib—CSK—nervous system—epilepsy syndrome	0.000179	0.00235	CbGeAlD
Dasatinib—LIMK2—central nervous system—epilepsy syndrome	0.000179	0.00235	CbGeAlD
Dasatinib—MAP4K5—medulla oblongata—epilepsy syndrome	0.000179	0.00235	CbGeAlD
Dasatinib—MAP3K3—medulla oblongata—epilepsy syndrome	0.000179	0.00235	CbGeAlD
Dasatinib—HCK—nervous system—epilepsy syndrome	0.000177	0.00232	CbGeAlD
Dasatinib—MAPK14—spinal cord—epilepsy syndrome	0.000176	0.00231	CbGeAlD
Dasatinib—RIPK2—head—epilepsy syndrome	0.000175	0.0023	CbGeAlD
Dasatinib—LIMK2—cerebellum—epilepsy syndrome	0.000175	0.0023	CbGeAlD
Dasatinib—STK35—central nervous system—epilepsy syndrome	0.000173	0.00228	CbGeAlD
Dasatinib—CSK—central nervous system—epilepsy syndrome	0.000172	0.00227	CbGeAlD
Dasatinib—SIK1—head—epilepsy syndrome	0.000171	0.00225	CbGeAlD
Dasatinib—EPHB6—medulla oblongata—epilepsy syndrome	0.000171	0.00225	CbGeAlD
Dasatinib—EPHB4—midbrain—epilepsy syndrome	0.000171	0.00225	CbGeAlD
Dasatinib—HCK—central nervous system—epilepsy syndrome	0.00017	0.00224	CbGeAlD
Dasatinib—STK35—cerebellum—epilepsy syndrome	0.00017	0.00223	CbGeAlD
Dasatinib—EPHA4—head—epilepsy syndrome	0.000169	0.00223	CbGeAlD
Dasatinib—ZAK—brain—epilepsy syndrome	0.000169	0.00222	CbGeAlD
Dasatinib—CSK—cerebellum—epilepsy syndrome	0.000168	0.00222	CbGeAlD
Dasatinib—ERBB3—head—epilepsy syndrome	0.000168	0.00221	CbGeAlD
Dasatinib—FYN—midbrain—epilepsy syndrome	0.000167	0.0022	CbGeAlD
Dasatinib—EPHB4—spinal cord—epilepsy syndrome	0.000167	0.00219	CbGeAlD
Dasatinib—MAP3K2—head—epilepsy syndrome	0.000166	0.00218	CbGeAlD
Dasatinib—JAK2—spinal cord—epilepsy syndrome	0.000165	0.00218	CbGeAlD
Dasatinib—EPHA5—brain—epilepsy syndrome	0.000165	0.00217	CbGeAlD
Dasatinib—ABL2—cerebellum—epilepsy syndrome	0.000165	0.00217	CbGeAlD
Dasatinib—YES1—medulla oblongata—epilepsy syndrome	0.000165	0.00217	CbGeAlD
Dasatinib—KIT—telencephalon—epilepsy syndrome	0.000165	0.00217	CbGeAlD
Dasatinib—LYN—brain—epilepsy syndrome	0.000164	0.00216	CbGeAlD
Dasatinib—MAP4K5—midbrain—epilepsy syndrome	0.000163	0.00215	CbGeAlD
Dasatinib—MAP3K3—midbrain—epilepsy syndrome	0.000163	0.00215	CbGeAlD
Dasatinib—FYN—spinal cord—epilepsy syndrome	0.000163	0.00215	CbGeAlD
Dasatinib—SIK1—nervous system—epilepsy syndrome	0.000162	0.00213	CbGeAlD
Dasatinib—MAP3K19—brain—epilepsy syndrome	0.000162	0.00213	CbGeAlD
Dasatinib—BMPR1B—brain—epilepsy syndrome	0.000162	0.00213	CbGeAlD
Dasatinib—ABL1—brainstem—epilepsy syndrome	0.000162	0.00213	CbGeAlD
Dasatinib—BTK—brain—epilepsy syndrome	0.000161	0.00212	CbGeAlD
Dasatinib—PDGFRB—telencephalon—epilepsy syndrome	0.000161	0.00212	CbGeAlD
Dasatinib—EPHA4—nervous system—epilepsy syndrome	0.000161	0.00211	CbGeAlD
Dasatinib—MAP4K5—spinal cord—epilepsy syndrome	0.000159	0.0021	CbGeAlD
Dasatinib—MAP3K3—spinal cord—epilepsy syndrome	0.000159	0.0021	CbGeAlD
Dasatinib—ERBB3—nervous system—epilepsy syndrome	0.000159	0.00209	CbGeAlD
Dasatinib—TNK2—brain—epilepsy syndrome	0.000159	0.00209	CbGeAlD
Dasatinib—MAP3K2—nervous system—epilepsy syndrome	0.000157	0.00207	CbGeAlD
Dasatinib—RIPK2—cerebellum—epilepsy syndrome	0.000156	0.00206	CbGeAlD
Dasatinib—SIK1—central nervous system—epilepsy syndrome	0.000156	0.00205	CbGeAlD
Dasatinib—MAPK14—head—epilepsy syndrome	0.000156	0.00205	CbGeAlD
Dasatinib—EPHB6—midbrain—epilepsy syndrome	0.000156	0.00205	CbGeAlD
Dasatinib—FGR—head—epilepsy syndrome	0.000156	0.00205	CbGeAlD
Dasatinib—EPHA4—central nervous system—epilepsy syndrome	0.000155	0.00203	CbGeAlD
Dasatinib—ERBB3—central nervous system—epilepsy syndrome	0.000153	0.00201	CbGeAlD
Dasatinib—SIK1—cerebellum—epilepsy syndrome	0.000153	0.00201	CbGeAlD
Dasatinib—EPHB6—spinal cord—epilepsy syndrome	0.000152	0.002	CbGeAlD
Dasatinib—MAP3K2—central nervous system—epilepsy syndrome	0.000152	0.00199	CbGeAlD
Dasatinib—EPHA4—cerebellum—epilepsy syndrome	0.000151	0.00199	CbGeAlD
Dasatinib—YES1—midbrain—epilepsy syndrome	0.000151	0.00198	CbGeAlD
Dasatinib—FMO3—head—epilepsy syndrome	0.00015	0.00198	CbGeAlD
Dasatinib—ERBB3—cerebellum—epilepsy syndrome	0.00015	0.00197	CbGeAlD
Dasatinib—TESK1—brain—epilepsy syndrome	0.000149	0.00196	CbGeAlD
Dasatinib—MAP3K2—cerebellum—epilepsy syndrome	0.000148	0.00195	CbGeAlD
Dasatinib—MAPK14—nervous system—epilepsy syndrome	0.000148	0.00195	CbGeAlD
Dasatinib—FGR—nervous system—epilepsy syndrome	0.000147	0.00194	CbGeAlD
Dasatinib—YES1—spinal cord—epilepsy syndrome	0.000147	0.00194	CbGeAlD
Dasatinib—JAK2—head—epilepsy syndrome	0.000147	0.00193	CbGeAlD
Dasatinib—STK36—brain—epilepsy syndrome	0.000147	0.00193	CbGeAlD
Dasatinib—EPHB3—brain—epilepsy syndrome	0.000147	0.00193	CbGeAlD
Dasatinib—MAP2K5—medulla oblongata—epilepsy syndrome	0.000146	0.00192	CbGeAlD
Dasatinib—EPHA2—head—epilepsy syndrome	0.000145	0.00191	CbGeAlD
Dasatinib—FYN—head—epilepsy syndrome	0.000145	0.00191	CbGeAlD
Dasatinib—PDGFRA—spinal cord—epilepsy syndrome	0.000144	0.0019	CbGeAlD
Dasatinib—ABL1—telencephalon—epilepsy syndrome	0.000143	0.00189	CbGeAlD
Dasatinib—CSF1R—medulla oblongata—epilepsy syndrome	0.000143	0.00188	CbGeAlD
Dasatinib—MAPK14—central nervous system—epilepsy syndrome	0.000143	0.00187	CbGeAlD
Dasatinib—FMO3—nervous system—epilepsy syndrome	0.000142	0.00187	CbGeAlD
Dasatinib—LIMK2—brain—epilepsy syndrome	0.000142	0.00187	CbGeAlD
Dasatinib—FGR—central nervous system—epilepsy syndrome	0.000142	0.00187	CbGeAlD
Dasatinib—MAP4K5—head—epilepsy syndrome	0.000142	0.00186	CbGeAlD
Dasatinib—MAP3K3—head—epilepsy syndrome	0.000142	0.00186	CbGeAlD
Dasatinib—SRC—spinal cord—epilepsy syndrome	0.000142	0.00186	CbGeAlD
Dasatinib—JAK2—nervous system—epilepsy syndrome	0.000139	0.00183	CbGeAlD
Dasatinib—MAPK14—cerebellum—epilepsy syndrome	0.000139	0.00183	CbGeAlD
Dasatinib—STK35—brain—epilepsy syndrome	0.000138	0.00181	CbGeAlD
Dasatinib—EPHA2—nervous system—epilepsy syndrome	0.000138	0.00181	CbGeAlD
Dasatinib—FYN—nervous system—epilepsy syndrome	0.000137	0.00181	CbGeAlD
Dasatinib—FMO3—central nervous system—epilepsy syndrome	0.000137	0.0018	CbGeAlD
Dasatinib—CSK—brain—epilepsy syndrome	0.000137	0.0018	CbGeAlD
Dasatinib—EPHB6—head—epilepsy syndrome	0.000135	0.00178	CbGeAlD
Dasatinib—HCK—brain—epilepsy syndrome	0.000135	0.00178	CbGeAlD
Dasatinib—MAP4K5—nervous system—epilepsy syndrome	0.000134	0.00177	CbGeAlD
Dasatinib—MAP3K3—nervous system—epilepsy syndrome	0.000134	0.00177	CbGeAlD
Dasatinib—ABL2—brain—epilepsy syndrome	0.000134	0.00177	CbGeAlD
Dasatinib—JAK2—central nervous system—epilepsy syndrome	0.000134	0.00176	CbGeAlD
Dasatinib—MAP2K5—midbrain—epilepsy syndrome	0.000134	0.00176	CbGeAlD
Dasatinib—EPHA2—central nervous system—epilepsy syndrome	0.000133	0.00174	CbGeAlD
Dasatinib—FYN—central nervous system—epilepsy syndrome	0.000132	0.00174	CbGeAlD
Dasatinib—EPHB4—cerebellum—epilepsy syndrome	0.000132	0.00174	CbGeAlD
Dasatinib—JAK2—cerebellum—epilepsy syndrome	0.000131	0.00172	CbGeAlD
Dasatinib—YES1—head—epilepsy syndrome	0.000131	0.00172	CbGeAlD
Dasatinib—CSF1R—midbrain—epilepsy syndrome	0.00013	0.00171	CbGeAlD
Dasatinib—MAP2K5—spinal cord—epilepsy syndrome	0.00013	0.00171	CbGeAlD
Dasatinib—KIT—medulla oblongata—epilepsy syndrome	0.000129	0.0017	CbGeAlD
Dasatinib—FYN—cerebellum—epilepsy syndrome	0.000129	0.0017	CbGeAlD
Dasatinib—MAP3K3—central nervous system—epilepsy syndrome	0.000129	0.0017	CbGeAlD
Dasatinib—MAP4K5—central nervous system—epilepsy syndrome	0.000129	0.0017	CbGeAlD
Dasatinib—EPHB6—nervous system—epilepsy syndrome	0.000128	0.00169	CbGeAlD
Dasatinib—PDGFRA—head—epilepsy syndrome	0.000128	0.00169	CbGeAlD
Dasatinib—CSF1R—spinal cord—epilepsy syndrome	0.000127	0.00167	CbGeAlD
Dasatinib—RIPK2—brain—epilepsy syndrome	0.000127	0.00167	CbGeAlD
Dasatinib—PDGFRB—medulla oblongata—epilepsy syndrome	0.000126	0.00166	CbGeAlD
Dasatinib—MAP4K5—cerebellum—epilepsy syndrome	0.000126	0.00166	CbGeAlD
Dasatinib—MAP3K3—cerebellum—epilepsy syndrome	0.000126	0.00166	CbGeAlD
Dasatinib—SRC—head—epilepsy syndrome	0.000126	0.00166	CbGeAlD
Dasatinib—YES1—nervous system—epilepsy syndrome	0.000124	0.00163	CbGeAlD
Dasatinib—SIK1—brain—epilepsy syndrome	0.000124	0.00163	CbGeAlD
Dasatinib—EPHB6—central nervous system—epilepsy syndrome	0.000124	0.00163	CbGeAlD
Dasatinib—EPHA4—brain—epilepsy syndrome	0.000123	0.00161	CbGeAlD
Dasatinib—PDGFRA—nervous system—epilepsy syndrome	0.000122	0.0016	CbGeAlD
Dasatinib—ERBB3—brain—epilepsy syndrome	0.000122	0.0016	CbGeAlD
Dasatinib—CYP1B1—telencephalon—epilepsy syndrome	0.000121	0.0016	CbGeAlD
Dasatinib—EPHB6—cerebellum—epilepsy syndrome	0.000121	0.00159	CbGeAlD
Dasatinib—MAP3K2—brain—epilepsy syndrome	0.00012	0.00158	CbGeAlD
Dasatinib—YES1—central nervous system—epilepsy syndrome	0.000119	0.00157	CbGeAlD
Dasatinib—SRC—nervous system—epilepsy syndrome	0.000119	0.00157	CbGeAlD
Dasatinib—KIT—midbrain—epilepsy syndrome	0.000118	0.00156	CbGeAlD
Dasatinib—PDGFRA—central nervous system—epilepsy syndrome	0.000117	0.00154	CbGeAlD
Dasatinib—YES1—cerebellum—epilepsy syndrome	0.000117	0.00154	CbGeAlD
Dasatinib—MAP2K5—head—epilepsy syndrome	0.000116	0.00152	CbGeAlD
Dasatinib—PDGFRB—midbrain—epilepsy syndrome	0.000116	0.00152	CbGeAlD
Dasatinib—KIT—spinal cord—epilepsy syndrome	0.000115	0.00152	CbGeAlD
Dasatinib—SRC—central nervous system—epilepsy syndrome	0.000115	0.00151	CbGeAlD
Dasatinib—PDGFRA—cerebellum—epilepsy syndrome	0.000115	0.00151	CbGeAlD
Dasatinib—MAPK14—brain—epilepsy syndrome	0.000113	0.00149	CbGeAlD
Dasatinib—CSF1R—head—epilepsy syndrome	0.000113	0.00149	CbGeAlD
Dasatinib—PDGFRB—spinal cord—epilepsy syndrome	0.000113	0.00148	CbGeAlD
Dasatinib—ABL1—medulla oblongata—epilepsy syndrome	0.000113	0.00148	CbGeAlD
Dasatinib—FGR—brain—epilepsy syndrome	0.000113	0.00148	CbGeAlD
Dasatinib—SRC—cerebellum—epilepsy syndrome	0.000112	0.00148	CbGeAlD
Dasatinib—MAP2K5—nervous system—epilepsy syndrome	0.00011	0.00144	CbGeAlD
Dasatinib—FMO3—brain—epilepsy syndrome	0.000109	0.00143	CbGeAlD
Dasatinib—EPHB4—brain—epilepsy syndrome	0.000107	0.00141	CbGeAlD
Dasatinib—CSF1R—nervous system—epilepsy syndrome	0.000107	0.00141	CbGeAlD
Dasatinib—JAK2—brain—epilepsy syndrome	0.000107	0.0014	CbGeAlD
Dasatinib—MAP2K5—central nervous system—epilepsy syndrome	0.000106	0.00139	CbGeAlD
Dasatinib—EPHA2—brain—epilepsy syndrome	0.000105	0.00138	CbGeAlD
Dasatinib—FYN—brain—epilepsy syndrome	0.000105	0.00138	CbGeAlD
Dasatinib—MAP2K5—cerebellum—epilepsy syndrome	0.000103	0.00136	CbGeAlD
Dasatinib—CSF1R—central nervous system—epilepsy syndrome	0.000103	0.00136	CbGeAlD
Dasatinib—ABL1—midbrain—epilepsy syndrome	0.000103	0.00135	CbGeAlD
Dasatinib—MAP4K5—brain—epilepsy syndrome	0.000103	0.00135	CbGeAlD
Dasatinib—MAP3K3—brain—epilepsy syndrome	0.000103	0.00135	CbGeAlD
Dasatinib—KIT—head—epilepsy syndrome	0.000103	0.00135	CbGeAlD
Dasatinib—CSF1R—cerebellum—epilepsy syndrome	0.000101	0.00133	CbGeAlD
Dasatinib—ABL1—spinal cord—epilepsy syndrome	0.000101	0.00132	CbGeAlD
Dasatinib—PDGFRB—head—epilepsy syndrome	0.0001	0.00132	CbGeAlD
Dasatinib—EPHB6—brain—epilepsy syndrome	9.81e-05	0.00129	CbGeAlD
Dasatinib—KIT—nervous system—epilepsy syndrome	9.73e-05	0.00128	CbGeAlD
Dasatinib—PDGFRB—nervous system—epilepsy syndrome	9.5e-05	0.00125	CbGeAlD
Dasatinib—YES1—brain—epilepsy syndrome	9.48e-05	0.00125	CbGeAlD
Dasatinib—KIT—central nervous system—epilepsy syndrome	9.37e-05	0.00123	CbGeAlD
Dasatinib—PDGFRA—brain—epilepsy syndrome	9.3e-05	0.00122	CbGeAlD
Dasatinib—KIT—cerebellum—epilepsy syndrome	9.15e-05	0.0012	CbGeAlD
Dasatinib—PDGFRB—central nervous system—epilepsy syndrome	9.15e-05	0.0012	CbGeAlD
Dasatinib—SRC—brain—epilepsy syndrome	9.12e-05	0.0012	CbGeAlD
Dasatinib—ABCG2—telencephalon—epilepsy syndrome	9.05e-05	0.00119	CbGeAlD
Dasatinib—PDGFRB—cerebellum—epilepsy syndrome	8.94e-05	0.00118	CbGeAlD
Dasatinib—ABL1—head—epilepsy syndrome	8.93e-05	0.00117	CbGeAlD
Dasatinib—ABL1—nervous system—epilepsy syndrome	8.47e-05	0.00111	CbGeAlD
Dasatinib—MAP2K5—brain—epilepsy syndrome	8.39e-05	0.0011	CbGeAlD
Dasatinib—CSF1R—brain—epilepsy syndrome	8.19e-05	0.00108	CbGeAlD
Dasatinib—ABL1—central nervous system—epilepsy syndrome	8.15e-05	0.00107	CbGeAlD
Dasatinib—ABL1—cerebellum—epilepsy syndrome	7.97e-05	0.00105	CbGeAlD
Dasatinib—CYP1B1—head—epilepsy syndrome	7.56e-05	0.000995	CbGeAlD
Dasatinib—KIT—brain—epilepsy syndrome	7.44e-05	0.000978	CbGeAlD
Dasatinib—PDGFRB—brain—epilepsy syndrome	7.26e-05	0.000955	CbGeAlD
Dasatinib—CYP1B1—nervous system—epilepsy syndrome	7.17e-05	0.000943	CbGeAlD
Dasatinib—ABCG2—medulla oblongata—epilepsy syndrome	7.11e-05	0.000935	CbGeAlD
Dasatinib—CYP1B1—central nervous system—epilepsy syndrome	6.9e-05	0.000908	CbGeAlD
Dasatinib—CYP1B1—cerebellum—epilepsy syndrome	6.75e-05	0.000888	CbGeAlD
Dasatinib—ABCG2—midbrain—epilepsy syndrome	6.5e-05	0.000854	CbGeAlD
Dasatinib—ABL1—brain—epilepsy syndrome	6.47e-05	0.000851	CbGeAlD
Dasatinib—ABCG2—spinal cord—epilepsy syndrome	6.34e-05	0.000834	CbGeAlD
Dasatinib—CYP1B1—brain—epilepsy syndrome	5.48e-05	0.000721	CbGeAlD
Dasatinib—CYP1A1—head—epilepsy syndrome	5.35e-05	0.000703	CbGeAlD
Dasatinib—CYP1A1—nervous system—epilepsy syndrome	5.07e-05	0.000667	CbGeAlD
Dasatinib—ABCG2—cerebellum—epilepsy syndrome	5.03e-05	0.000661	CbGeAlD
Dasatinib—CYP1A1—central nervous system—epilepsy syndrome	4.88e-05	0.000642	CbGeAlD
Dasatinib—ABCB1—forebrain—epilepsy syndrome	4.85e-05	0.000638	CbGeAlD
Dasatinib—ABCB1—telencephalon—epilepsy syndrome	4.46e-05	0.000587	CbGeAlD
Dasatinib—ABCG2—brain—epilepsy syndrome	4.08e-05	0.000537	CbGeAlD
Dasatinib—CYP1A1—brain—epilepsy syndrome	3.88e-05	0.00051	CbGeAlD
Dasatinib—CYP3A4—nervous system—epilepsy syndrome	3.72e-05	0.000489	CbGeAlD
Dasatinib—CYP3A4—central nervous system—epilepsy syndrome	3.58e-05	0.000471	CbGeAlD
Dasatinib—ABCB1—medulla oblongata—epilepsy syndrome	3.5e-05	0.000461	CbGeAlD
Dasatinib—ABCB1—midbrain—epilepsy syndrome	3.2e-05	0.000421	CbGeAlD
Dasatinib—Hypertension—Pregabalin—epilepsy syndrome	3.15e-05	0.000201	CcSEcCtD
Dasatinib—Vomiting—Diazepam—epilepsy syndrome	3.15e-05	0.000201	CcSEcCtD
Dasatinib—Anorexia—Valproic Acid—epilepsy syndrome	3.14e-05	0.0002	CcSEcCtD
Dasatinib—Tremor—Gabapentin—epilepsy syndrome	3.13e-05	0.0002	CcSEcCtD
Dasatinib—ABCB1—spinal cord—epilepsy syndrome	3.13e-05	0.000411	CbGeAlD
Dasatinib—Rash—Diazepam—epilepsy syndrome	3.12e-05	0.000199	CcSEcCtD
Dasatinib—Dermatitis—Diazepam—epilepsy syndrome	3.12e-05	0.000199	CcSEcCtD
Dasatinib—Visual impairment—Topiramate—epilepsy syndrome	3.11e-05	0.000198	CcSEcCtD
Dasatinib—Chest pain—Pregabalin—epilepsy syndrome	3.1e-05	0.000198	CcSEcCtD
Dasatinib—Arthralgia—Pregabalin—epilepsy syndrome	3.1e-05	0.000198	CcSEcCtD
Dasatinib—Myalgia—Pregabalin—epilepsy syndrome	3.1e-05	0.000198	CcSEcCtD
Dasatinib—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.1e-05	0.000198	CcSEcCtD
Dasatinib—Dizziness—Zonisamide—epilepsy syndrome	3.1e-05	0.000198	CcSEcCtD
Dasatinib—Headache—Diazepam—epilepsy syndrome	3.1e-05	0.000198	CcSEcCtD
Dasatinib—Anxiety—Pregabalin—epilepsy syndrome	3.09e-05	0.000197	CcSEcCtD
Dasatinib—Diarrhoea—Clonazepam—epilepsy syndrome	3.09e-05	0.000197	CcSEcCtD
Dasatinib—Anaemia—Gabapentin—epilepsy syndrome	3.09e-05	0.000197	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.08e-05	0.000196	CcSEcCtD
Dasatinib—Hypotension—Valproic Acid—epilepsy syndrome	3.07e-05	0.000196	CcSEcCtD
Dasatinib—Asthenia—Carbamazepine—epilepsy syndrome	3.07e-05	0.000196	CcSEcCtD
Dasatinib—Diarrhoea—Phenytoin—epilepsy syndrome	3.07e-05	0.000196	CcSEcCtD
Dasatinib—Discomfort—Pregabalin—epilepsy syndrome	3.06e-05	0.000195	CcSEcCtD
Dasatinib—Nausea—Fosphenytoin—epilepsy syndrome	3.06e-05	0.000195	CcSEcCtD
Dasatinib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.05e-05	0.000195	CcSEcCtD
Dasatinib—Erythema multiforme—Topiramate—epilepsy syndrome	3.05e-05	0.000195	CcSEcCtD
Dasatinib—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.05e-05	0.000195	CcSEcCtD
Dasatinib—Vomiting—Felbamate—epilepsy syndrome	3.04e-05	0.000194	CcSEcCtD
Dasatinib—Pruritus—Carbamazepine—epilepsy syndrome	3.03e-05	0.000193	CcSEcCtD
Dasatinib—Rash—Felbamate—epilepsy syndrome	3.02e-05	0.000193	CcSEcCtD
Dasatinib—Eye disorder—Topiramate—epilepsy syndrome	3.02e-05	0.000192	CcSEcCtD
Dasatinib—Dermatitis—Felbamate—epilepsy syndrome	3.02e-05	0.000192	CcSEcCtD
Dasatinib—Malaise—Gabapentin—epilepsy syndrome	3.01e-05	0.000192	CcSEcCtD
Dasatinib—Tinnitus—Topiramate—epilepsy syndrome	3.01e-05	0.000192	CcSEcCtD
Dasatinib—Vertigo—Gabapentin—epilepsy syndrome	3e-05	0.000191	CcSEcCtD
Dasatinib—Headache—Felbamate—epilepsy syndrome	3e-05	0.000191	CcSEcCtD
Dasatinib—Confusional state—Pregabalin—epilepsy syndrome	3e-05	0.000191	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3e-05	0.000191	CcSEcCtD
Dasatinib—Flushing—Topiramate—epilepsy syndrome	3e-05	0.000191	CcSEcCtD
Dasatinib—Cardiac disorder—Topiramate—epilepsy syndrome	3e-05	0.000191	CcSEcCtD
Dasatinib—Syncope—Gabapentin—epilepsy syndrome	3e-05	0.000191	CcSEcCtD
Dasatinib—Dizziness—Clonazepam—epilepsy syndrome	2.99e-05	0.000191	CcSEcCtD
Dasatinib—Nausea—Vigabatrin—epilepsy syndrome	2.99e-05	0.00019	CcSEcCtD
Dasatinib—Vomiting—Zonisamide—epilepsy syndrome	2.98e-05	0.00019	CcSEcCtD
Dasatinib—Insomnia—Valproic Acid—epilepsy syndrome	2.98e-05	0.00019	CcSEcCtD
Dasatinib—Oedema—Pregabalin—epilepsy syndrome	2.97e-05	0.00019	CcSEcCtD
Dasatinib—Asthenia—Lamotrigine—epilepsy syndrome	2.97e-05	0.000189	CcSEcCtD
Dasatinib—Dizziness—Phenytoin—epilepsy syndrome	2.97e-05	0.000189	CcSEcCtD
Dasatinib—Rash—Zonisamide—epilepsy syndrome	2.96e-05	0.000188	CcSEcCtD
Dasatinib—Infection—Pregabalin—epilepsy syndrome	2.95e-05	0.000188	CcSEcCtD
Dasatinib—Palpitations—Gabapentin—epilepsy syndrome	2.95e-05	0.000188	CcSEcCtD
Dasatinib—Dermatitis—Zonisamide—epilepsy syndrome	2.95e-05	0.000188	CcSEcCtD
Dasatinib—Dizziness—Oxcarbazepine—epilepsy syndrome	2.95e-05	0.000188	CcSEcCtD
Dasatinib—Nausea—Diazepam—epilepsy syndrome	2.94e-05	0.000187	CcSEcCtD
Dasatinib—Loss of consciousness—Gabapentin—epilepsy syndrome	2.94e-05	0.000187	CcSEcCtD
Dasatinib—Headache—Zonisamide—epilepsy syndrome	2.94e-05	0.000187	CcSEcCtD
Dasatinib—Dyspnoea—Valproic Acid—epilepsy syndrome	2.93e-05	0.000187	CcSEcCtD
Dasatinib—Diarrhoea—Carbamazepine—epilepsy syndrome	2.93e-05	0.000187	CcSEcCtD
Dasatinib—Angiopathy—Topiramate—epilepsy syndrome	2.93e-05	0.000187	CcSEcCtD
Dasatinib—Pruritus—Lamotrigine—epilepsy syndrome	2.93e-05	0.000187	CcSEcCtD
Dasatinib—Shock—Pregabalin—epilepsy syndrome	2.93e-05	0.000187	CcSEcCtD
Dasatinib—Somnolence—Valproic Acid—epilepsy syndrome	2.92e-05	0.000187	CcSEcCtD
Dasatinib—Immune system disorder—Topiramate—epilepsy syndrome	2.92e-05	0.000186	CcSEcCtD
Dasatinib—Nervous system disorder—Pregabalin—epilepsy syndrome	2.92e-05	0.000186	CcSEcCtD
Dasatinib—Cough—Gabapentin—epilepsy syndrome	2.92e-05	0.000186	CcSEcCtD
Dasatinib—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.91e-05	0.000186	CcSEcCtD
Dasatinib—Mediastinal disorder—Topiramate—epilepsy syndrome	2.91e-05	0.000186	CcSEcCtD
Dasatinib—Tachycardia—Pregabalin—epilepsy syndrome	2.9e-05	0.000185	CcSEcCtD
Dasatinib—Chills—Topiramate—epilepsy syndrome	2.9e-05	0.000185	CcSEcCtD
Dasatinib—Dyspepsia—Valproic Acid—epilepsy syndrome	2.9e-05	0.000185	CcSEcCtD
Dasatinib—Convulsion—Gabapentin—epilepsy syndrome	2.89e-05	0.000185	CcSEcCtD
Dasatinib—Skin disorder—Pregabalin—epilepsy syndrome	2.89e-05	0.000184	CcSEcCtD
Dasatinib—Hypertension—Gabapentin—epilepsy syndrome	2.88e-05	0.000184	CcSEcCtD
Dasatinib—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.87e-05	0.000183	CcSEcCtD
Dasatinib—Vomiting—Clonazepam—epilepsy syndrome	2.87e-05	0.000183	CcSEcCtD
Dasatinib—Decreased appetite—Valproic Acid—epilepsy syndrome	2.86e-05	0.000182	CcSEcCtD
Dasatinib—Alopecia—Topiramate—epilepsy syndrome	2.85e-05	0.000182	CcSEcCtD
Dasatinib—Vomiting—Phenytoin—epilepsy syndrome	2.85e-05	0.000182	CcSEcCtD
Dasatinib—Rash—Clonazepam—epilepsy syndrome	2.85e-05	0.000182	CcSEcCtD
Dasatinib—Dermatitis—Clonazepam—epilepsy syndrome	2.85e-05	0.000181	CcSEcCtD
Dasatinib—Chest pain—Gabapentin—epilepsy syndrome	2.84e-05	0.000181	CcSEcCtD
Dasatinib—Myalgia—Gabapentin—epilepsy syndrome	2.84e-05	0.000181	CcSEcCtD
Dasatinib—Arthralgia—Gabapentin—epilepsy syndrome	2.84e-05	0.000181	CcSEcCtD
Dasatinib—Nausea—Felbamate—epilepsy syndrome	2.84e-05	0.000181	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.84e-05	0.000181	CcSEcCtD
Dasatinib—Vomiting—Oxcarbazepine—epilepsy syndrome	2.84e-05	0.000181	CcSEcCtD
Dasatinib—Fatigue—Valproic Acid—epilepsy syndrome	2.84e-05	0.000181	CcSEcCtD
Dasatinib—Anxiety—Gabapentin—epilepsy syndrome	2.83e-05	0.000181	CcSEcCtD
Dasatinib—Anorexia—Pregabalin—epilepsy syndrome	2.83e-05	0.000181	CcSEcCtD
Dasatinib—Dizziness—Carbamazepine—epilepsy syndrome	2.83e-05	0.000181	CcSEcCtD
Dasatinib—Diarrhoea—Lamotrigine—epilepsy syndrome	2.83e-05	0.000181	CcSEcCtD
Dasatinib—Headache—Clonazepam—epilepsy syndrome	2.83e-05	0.00018	CcSEcCtD
Dasatinib—Rash—Phenytoin—epilepsy syndrome	2.83e-05	0.00018	CcSEcCtD
Dasatinib—Mental disorder—Topiramate—epilepsy syndrome	2.83e-05	0.00018	CcSEcCtD
Dasatinib—Dermatitis—Phenytoin—epilepsy syndrome	2.83e-05	0.00018	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.82e-05	0.00018	CcSEcCtD
Dasatinib—Rash—Oxcarbazepine—epilepsy syndrome	2.81e-05	0.000179	CcSEcCtD
Dasatinib—Constipation—Valproic Acid—epilepsy syndrome	2.81e-05	0.000179	CcSEcCtD
Dasatinib—Pain—Valproic Acid—epilepsy syndrome	2.81e-05	0.000179	CcSEcCtD
Dasatinib—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.81e-05	0.000179	CcSEcCtD
Dasatinib—Headache—Phenytoin—epilepsy syndrome	2.81e-05	0.000179	CcSEcCtD
Dasatinib—Malnutrition—Topiramate—epilepsy syndrome	2.81e-05	0.000179	CcSEcCtD
Dasatinib—Erythema—Topiramate—epilepsy syndrome	2.81e-05	0.000179	CcSEcCtD
Dasatinib—Discomfort—Gabapentin—epilepsy syndrome	2.81e-05	0.000179	CcSEcCtD
Dasatinib—Headache—Oxcarbazepine—epilepsy syndrome	2.8e-05	0.000178	CcSEcCtD
Dasatinib—Nausea—Zonisamide—epilepsy syndrome	2.78e-05	0.000178	CcSEcCtD
Dasatinib—Hypotension—Pregabalin—epilepsy syndrome	2.78e-05	0.000177	CcSEcCtD
Dasatinib—ABCB1—head—epilepsy syndrome	2.78e-05	0.000365	CbGeAlD
Dasatinib—Dysgeusia—Topiramate—epilepsy syndrome	2.75e-05	0.000176	CcSEcCtD
Dasatinib—Confusional state—Gabapentin—epilepsy syndrome	2.75e-05	0.000175	CcSEcCtD
Dasatinib—Dizziness—Lamotrigine—epilepsy syndrome	2.74e-05	0.000175	CcSEcCtD
Dasatinib—Oedema—Gabapentin—epilepsy syndrome	2.73e-05	0.000174	CcSEcCtD
Dasatinib—Vomiting—Carbamazepine—epilepsy syndrome	2.72e-05	0.000174	CcSEcCtD
Dasatinib—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.71e-05	0.000173	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.71e-05	0.000173	CcSEcCtD
Dasatinib—Infection—Gabapentin—epilepsy syndrome	2.71e-05	0.000173	CcSEcCtD
Dasatinib—Muscle spasms—Topiramate—epilepsy syndrome	2.7e-05	0.000172	CcSEcCtD
Dasatinib—Rash—Carbamazepine—epilepsy syndrome	2.7e-05	0.000172	CcSEcCtD
Dasatinib—Dermatitis—Carbamazepine—epilepsy syndrome	2.7e-05	0.000172	CcSEcCtD
Dasatinib—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.69e-05	0.000172	CcSEcCtD
Dasatinib—Insomnia—Pregabalin—epilepsy syndrome	2.69e-05	0.000172	CcSEcCtD
Dasatinib—Nausea—Clonazepam—epilepsy syndrome	2.68e-05	0.000171	CcSEcCtD
Dasatinib—Headache—Carbamazepine—epilepsy syndrome	2.68e-05	0.000171	CcSEcCtD
Dasatinib—Shock—Gabapentin—epilepsy syndrome	2.68e-05	0.000171	CcSEcCtD
Dasatinib—Nervous system disorder—Gabapentin—epilepsy syndrome	2.67e-05	0.000171	CcSEcCtD
Dasatinib—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.67e-05	0.00017	CcSEcCtD
Dasatinib—Nausea—Phenytoin—epilepsy syndrome	2.67e-05	0.00017	CcSEcCtD
Dasatinib—Tachycardia—Gabapentin—epilepsy syndrome	2.66e-05	0.00017	CcSEcCtD
Dasatinib—Dyspnoea—Pregabalin—epilepsy syndrome	2.65e-05	0.000169	CcSEcCtD
Dasatinib—Nausea—Oxcarbazepine—epilepsy syndrome	2.65e-05	0.000169	CcSEcCtD
Dasatinib—Vision blurred—Topiramate—epilepsy syndrome	2.65e-05	0.000169	CcSEcCtD
Dasatinib—Skin disorder—Gabapentin—epilepsy syndrome	2.65e-05	0.000169	CcSEcCtD
Dasatinib—Somnolence—Pregabalin—epilepsy syndrome	2.64e-05	0.000169	CcSEcCtD
Dasatinib—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.64e-05	0.000168	CcSEcCtD
Dasatinib—Tremor—Topiramate—epilepsy syndrome	2.63e-05	0.000168	CcSEcCtD
Dasatinib—ABCB1—nervous system—epilepsy syndrome	2.63e-05	0.000346	CbGeAlD
Dasatinib—Vomiting—Lamotrigine—epilepsy syndrome	2.63e-05	0.000168	CcSEcCtD
Dasatinib—Urticaria—Valproic Acid—epilepsy syndrome	2.61e-05	0.000167	CcSEcCtD
Dasatinib—Rash—Lamotrigine—epilepsy syndrome	2.61e-05	0.000166	CcSEcCtD
Dasatinib—Ill-defined disorder—Topiramate—epilepsy syndrome	2.61e-05	0.000166	CcSEcCtD
Dasatinib—Dermatitis—Lamotrigine—epilepsy syndrome	2.61e-05	0.000166	CcSEcCtD
Dasatinib—Abdominal pain—Valproic Acid—epilepsy syndrome	2.6e-05	0.000166	CcSEcCtD
Dasatinib—Body temperature increased—Valproic Acid—epilepsy syndrome	2.6e-05	0.000166	CcSEcCtD
Dasatinib—Anorexia—Gabapentin—epilepsy syndrome	2.6e-05	0.000166	CcSEcCtD
Dasatinib—Anaemia—Topiramate—epilepsy syndrome	2.6e-05	0.000166	CcSEcCtD
Dasatinib—Headache—Lamotrigine—epilepsy syndrome	2.59e-05	0.000165	CcSEcCtD
Dasatinib—Decreased appetite—Pregabalin—epilepsy syndrome	2.59e-05	0.000165	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.57e-05	0.000164	CcSEcCtD
Dasatinib—Fatigue—Pregabalin—epilepsy syndrome	2.56e-05	0.000164	CcSEcCtD
Dasatinib—Hypotension—Gabapentin—epilepsy syndrome	2.55e-05	0.000163	CcSEcCtD
Dasatinib—Nausea—Carbamazepine—epilepsy syndrome	2.54e-05	0.000162	CcSEcCtD
Dasatinib—Pain—Pregabalin—epilepsy syndrome	2.54e-05	0.000162	CcSEcCtD
Dasatinib—Constipation—Pregabalin—epilepsy syndrome	2.54e-05	0.000162	CcSEcCtD
Dasatinib—ABCB1—central nervous system—epilepsy syndrome	2.54e-05	0.000333	CbGeAlD
Dasatinib—Malaise—Topiramate—epilepsy syndrome	2.53e-05	0.000162	CcSEcCtD
Dasatinib—Vertigo—Topiramate—epilepsy syndrome	2.53e-05	0.000161	CcSEcCtD
Dasatinib—Syncope—Topiramate—epilepsy syndrome	2.52e-05	0.000161	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.48e-05	0.000158	CcSEcCtD
Dasatinib—Palpitations—Topiramate—epilepsy syndrome	2.48e-05	0.000158	CcSEcCtD
Dasatinib—ABCB1—cerebellum—epilepsy syndrome	2.48e-05	0.000326	CbGeAlD
Dasatinib—Loss of consciousness—Topiramate—epilepsy syndrome	2.47e-05	0.000158	CcSEcCtD
Dasatinib—Insomnia—Gabapentin—epilepsy syndrome	2.47e-05	0.000157	CcSEcCtD
Dasatinib—Nausea—Lamotrigine—epilepsy syndrome	2.46e-05	0.000157	CcSEcCtD
Dasatinib—Cough—Topiramate—epilepsy syndrome	2.45e-05	0.000156	CcSEcCtD
Dasatinib—Feeling abnormal—Pregabalin—epilepsy syndrome	2.45e-05	0.000156	CcSEcCtD
Dasatinib—Convulsion—Topiramate—epilepsy syndrome	2.44e-05	0.000155	CcSEcCtD
Dasatinib—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.43e-05	0.000155	CcSEcCtD
Dasatinib—Dyspnoea—Gabapentin—epilepsy syndrome	2.43e-05	0.000155	CcSEcCtD
Dasatinib—Hypertension—Topiramate—epilepsy syndrome	2.43e-05	0.000155	CcSEcCtD
Dasatinib—Somnolence—Gabapentin—epilepsy syndrome	2.42e-05	0.000155	CcSEcCtD
Dasatinib—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.42e-05	0.000155	CcSEcCtD
Dasatinib—Dyspepsia—Gabapentin—epilepsy syndrome	2.4e-05	0.000153	CcSEcCtD
Dasatinib—Chest pain—Topiramate—epilepsy syndrome	2.39e-05	0.000153	CcSEcCtD
Dasatinib—Arthralgia—Topiramate—epilepsy syndrome	2.39e-05	0.000153	CcSEcCtD
Dasatinib—Myalgia—Topiramate—epilepsy syndrome	2.39e-05	0.000153	CcSEcCtD
Dasatinib—Anxiety—Topiramate—epilepsy syndrome	2.38e-05	0.000152	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.38e-05	0.000152	CcSEcCtD
Dasatinib—Decreased appetite—Gabapentin—epilepsy syndrome	2.37e-05	0.000151	CcSEcCtD
Dasatinib—Discomfort—Topiramate—epilepsy syndrome	2.36e-05	0.000151	CcSEcCtD
Dasatinib—Urticaria—Pregabalin—epilepsy syndrome	2.36e-05	0.000151	CcSEcCtD
Dasatinib—Asthenia—Valproic Acid—epilepsy syndrome	2.36e-05	0.000151	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.35e-05	0.00015	CcSEcCtD
Dasatinib—Fatigue—Gabapentin—epilepsy syndrome	2.35e-05	0.00015	CcSEcCtD
Dasatinib—Body temperature increased—Pregabalin—epilepsy syndrome	2.35e-05	0.00015	CcSEcCtD
Dasatinib—Abdominal pain—Pregabalin—epilepsy syndrome	2.35e-05	0.00015	CcSEcCtD
Dasatinib—Constipation—Gabapentin—epilepsy syndrome	2.33e-05	0.000149	CcSEcCtD
Dasatinib—Pain—Gabapentin—epilepsy syndrome	2.33e-05	0.000149	CcSEcCtD
Dasatinib—Pruritus—Valproic Acid—epilepsy syndrome	2.33e-05	0.000148	CcSEcCtD
Dasatinib—Confusional state—Topiramate—epilepsy syndrome	2.31e-05	0.000148	CcSEcCtD
Dasatinib—Oedema—Topiramate—epilepsy syndrome	2.29e-05	0.000146	CcSEcCtD
Dasatinib—Infection—Topiramate—epilepsy syndrome	2.28e-05	0.000145	CcSEcCtD
Dasatinib—Shock—Topiramate—epilepsy syndrome	2.26e-05	0.000144	CcSEcCtD
Dasatinib—Diarrhoea—Valproic Acid—epilepsy syndrome	2.25e-05	0.000144	CcSEcCtD
Dasatinib—Nervous system disorder—Topiramate—epilepsy syndrome	2.25e-05	0.000143	CcSEcCtD
Dasatinib—Feeling abnormal—Gabapentin—epilepsy syndrome	2.25e-05	0.000143	CcSEcCtD
Dasatinib—Thrombocytopenia—Topiramate—epilepsy syndrome	2.25e-05	0.000143	CcSEcCtD
Dasatinib—Tachycardia—Topiramate—epilepsy syndrome	2.24e-05	0.000143	CcSEcCtD
Dasatinib—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.23e-05	0.000142	CcSEcCtD
Dasatinib—Skin disorder—Topiramate—epilepsy syndrome	2.23e-05	0.000142	CcSEcCtD
Dasatinib—Hyperhidrosis—Topiramate—epilepsy syndrome	2.22e-05	0.000141	CcSEcCtD
Dasatinib—Hypersensitivity—Pregabalin—epilepsy syndrome	2.19e-05	0.00014	CcSEcCtD
Dasatinib—Anorexia—Topiramate—epilepsy syndrome	2.19e-05	0.000139	CcSEcCtD
Dasatinib—Dizziness—Valproic Acid—epilepsy syndrome	2.18e-05	0.000139	CcSEcCtD
Dasatinib—Urticaria—Gabapentin—epilepsy syndrome	2.17e-05	0.000138	CcSEcCtD
Dasatinib—Abdominal pain—Gabapentin—epilepsy syndrome	2.16e-05	0.000137	CcSEcCtD
Dasatinib—Body temperature increased—Gabapentin—epilepsy syndrome	2.16e-05	0.000137	CcSEcCtD
Dasatinib—Hypotension—Topiramate—epilepsy syndrome	2.14e-05	0.000137	CcSEcCtD
Dasatinib—Asthenia—Pregabalin—epilepsy syndrome	2.13e-05	0.000136	CcSEcCtD
Dasatinib—Pruritus—Pregabalin—epilepsy syndrome	2.1e-05	0.000134	CcSEcCtD
Dasatinib—Vomiting—Valproic Acid—epilepsy syndrome	2.09e-05	0.000133	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.09e-05	0.000133	CcSEcCtD
Dasatinib—Insomnia—Topiramate—epilepsy syndrome	2.07e-05	0.000132	CcSEcCtD
Dasatinib—Rash—Valproic Acid—epilepsy syndrome	2.07e-05	0.000132	CcSEcCtD
Dasatinib—Dermatitis—Valproic Acid—epilepsy syndrome	2.07e-05	0.000132	CcSEcCtD
Dasatinib—Headache—Valproic Acid—epilepsy syndrome	2.06e-05	0.000131	CcSEcCtD
Dasatinib—Dyspnoea—Topiramate—epilepsy syndrome	2.05e-05	0.00013	CcSEcCtD
Dasatinib—Somnolence—Topiramate—epilepsy syndrome	2.04e-05	0.00013	CcSEcCtD
Dasatinib—Diarrhoea—Pregabalin—epilepsy syndrome	2.03e-05	0.00013	CcSEcCtD
Dasatinib—Dyspepsia—Topiramate—epilepsy syndrome	2.02e-05	0.000129	CcSEcCtD
Dasatinib—ABCB1—brain—epilepsy syndrome	2.01e-05	0.000265	CbGeAlD
Dasatinib—Hypersensitivity—Gabapentin—epilepsy syndrome	2.01e-05	0.000128	CcSEcCtD
Dasatinib—Decreased appetite—Topiramate—epilepsy syndrome	1.99e-05	0.000127	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.98e-05	0.000126	CcSEcCtD
Dasatinib—Fatigue—Topiramate—epilepsy syndrome	1.98e-05	0.000126	CcSEcCtD
Dasatinib—Dizziness—Pregabalin—epilepsy syndrome	1.97e-05	0.000125	CcSEcCtD
Dasatinib—Pain—Topiramate—epilepsy syndrome	1.96e-05	0.000125	CcSEcCtD
Dasatinib—Constipation—Topiramate—epilepsy syndrome	1.96e-05	0.000125	CcSEcCtD
Dasatinib—Asthenia—Gabapentin—epilepsy syndrome	1.96e-05	0.000125	CcSEcCtD
Dasatinib—Nausea—Valproic Acid—epilepsy syndrome	1.95e-05	0.000125	CcSEcCtD
Dasatinib—Pruritus—Gabapentin—epilepsy syndrome	1.93e-05	0.000123	CcSEcCtD
Dasatinib—Vomiting—Pregabalin—epilepsy syndrome	1.89e-05	0.000121	CcSEcCtD
Dasatinib—Feeling abnormal—Topiramate—epilepsy syndrome	1.89e-05	0.000121	CcSEcCtD
Dasatinib—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.88e-05	0.00012	CcSEcCtD
Dasatinib—Rash—Pregabalin—epilepsy syndrome	1.88e-05	0.00012	CcSEcCtD
Dasatinib—Dermatitis—Pregabalin—epilepsy syndrome	1.87e-05	0.000119	CcSEcCtD
Dasatinib—Diarrhoea—Gabapentin—epilepsy syndrome	1.87e-05	0.000119	CcSEcCtD
Dasatinib—Headache—Pregabalin—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Dasatinib—Urticaria—Topiramate—epilepsy syndrome	1.82e-05	0.000116	CcSEcCtD
Dasatinib—Body temperature increased—Topiramate—epilepsy syndrome	1.81e-05	0.000116	CcSEcCtD
Dasatinib—Abdominal pain—Topiramate—epilepsy syndrome	1.81e-05	0.000116	CcSEcCtD
Dasatinib—Dizziness—Gabapentin—epilepsy syndrome	1.8e-05	0.000115	CcSEcCtD
Dasatinib—Nausea—Pregabalin—epilepsy syndrome	1.77e-05	0.000113	CcSEcCtD
Dasatinib—Vomiting—Gabapentin—epilepsy syndrome	1.73e-05	0.000111	CcSEcCtD
Dasatinib—Rash—Gabapentin—epilepsy syndrome	1.72e-05	0.00011	CcSEcCtD
Dasatinib—Dermatitis—Gabapentin—epilepsy syndrome	1.72e-05	0.00011	CcSEcCtD
Dasatinib—Headache—Gabapentin—epilepsy syndrome	1.71e-05	0.000109	CcSEcCtD
Dasatinib—Hypersensitivity—Topiramate—epilepsy syndrome	1.69e-05	0.000108	CcSEcCtD
Dasatinib—Asthenia—Topiramate—epilepsy syndrome	1.65e-05	0.000105	CcSEcCtD
Dasatinib—Pruritus—Topiramate—epilepsy syndrome	1.62e-05	0.000104	CcSEcCtD
Dasatinib—Nausea—Gabapentin—epilepsy syndrome	1.62e-05	0.000103	CcSEcCtD
Dasatinib—Diarrhoea—Topiramate—epilepsy syndrome	1.57e-05	0.0001	CcSEcCtD
Dasatinib—Dizziness—Topiramate—epilepsy syndrome	1.52e-05	9.68e-05	CcSEcCtD
Dasatinib—Vomiting—Topiramate—epilepsy syndrome	1.46e-05	9.3e-05	CcSEcCtD
Dasatinib—Rash—Topiramate—epilepsy syndrome	1.45e-05	9.23e-05	CcSEcCtD
Dasatinib—Dermatitis—Topiramate—epilepsy syndrome	1.45e-05	9.22e-05	CcSEcCtD
Dasatinib—Headache—Topiramate—epilepsy syndrome	1.44e-05	9.17e-05	CcSEcCtD
Dasatinib—Nausea—Topiramate—epilepsy syndrome	1.36e-05	8.69e-05	CcSEcCtD
Dasatinib—YES1—Signaling Pathways—CASP3—epilepsy syndrome	5.39e-07	3.63e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—FGF2—epilepsy syndrome	5.38e-07	3.63e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	5.38e-07	3.63e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—SRC—epilepsy syndrome	5.34e-07	3.61e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—POMC—epilepsy syndrome	5.34e-07	3.6e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—RELA—epilepsy syndrome	5.33e-07	3.6e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—SRC—epilepsy syndrome	5.33e-07	3.6e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCL2—epilepsy syndrome	5.31e-07	3.58e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	5.29e-07	3.57e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TSC2—epilepsy syndrome	5.29e-07	3.57e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AGT—epilepsy syndrome	5.28e-07	3.56e-06	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—AKT1—epilepsy syndrome	5.26e-07	3.55e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—YWHAZ—epilepsy syndrome	5.23e-07	3.53e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—JUN—epilepsy syndrome	5.23e-07	3.53e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MTOR—epilepsy syndrome	5.23e-07	3.53e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCL2—epilepsy syndrome	5.22e-07	3.53e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CAT—epilepsy syndrome	5.22e-07	3.52e-06	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—AKT1—epilepsy syndrome	5.21e-07	3.52e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—VEGFA—epilepsy syndrome	5.21e-07	3.51e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	5.19e-07	3.5e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NGF—epilepsy syndrome	5.18e-07	3.49e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APOE—epilepsy syndrome	5.17e-07	3.49e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ALB—epilepsy syndrome	5.16e-07	3.48e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—POMC—epilepsy syndrome	5.15e-07	3.48e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—POMC—epilepsy syndrome	5.14e-07	3.47e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.14e-07	3.47e-06	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—AKT1—epilepsy syndrome	5.14e-07	3.47e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—SRC—epilepsy syndrome	5.13e-07	3.46e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—BCL2—epilepsy syndrome	5.11e-07	3.45e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—MTOR—epilepsy syndrome	5.11e-07	3.45e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—SRC—epilepsy syndrome	5.1e-07	3.44e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1B—epilepsy syndrome	5.1e-07	3.44e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MMP9—epilepsy syndrome	5.09e-07	3.43e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PLCB1—epilepsy syndrome	5.08e-07	3.43e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	5.08e-07	3.43e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—POMC—epilepsy syndrome	5.08e-07	3.43e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—KDR—epilepsy syndrome	5.07e-07	3.42e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—TH—epilepsy syndrome	5.07e-07	3.42e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—SRC—epilepsy syndrome	5.06e-07	3.42e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—PTGS2—epilepsy syndrome	5.06e-07	3.42e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	5.06e-07	3.41e-06	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—AKT1—epilepsy syndrome	5.06e-07	3.41e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—RELA—epilepsy syndrome	5.05e-07	3.41e-06	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—AKT1—epilepsy syndrome	5.05e-07	3.41e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCR5—epilepsy syndrome	5.04e-07	3.4e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCL2—epilepsy syndrome	5.03e-07	3.39e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	5.03e-07	3.39e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GPX1—epilepsy syndrome	5e-07	3.37e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—RELA—epilepsy syndrome	5e-07	3.37e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.99e-07	3.37e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—FGF2—epilepsy syndrome	4.97e-07	3.35e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCL2—epilepsy syndrome	4.97e-07	3.35e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MTOR—epilepsy syndrome	4.95e-07	3.34e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—JUN—epilepsy syndrome	4.94e-07	3.34e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR2A—epilepsy syndrome	4.93e-07	3.33e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—SRC—epilepsy syndrome	4.92e-07	3.32e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.91e-07	3.32e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.91e-07	3.32e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—MTOR—epilepsy syndrome	4.9e-07	3.31e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—FGF2—epilepsy syndrome	4.9e-07	3.31e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PRKCB—epilepsy syndrome	4.88e-07	3.29e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6ST—epilepsy syndrome	4.86e-07	3.28e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CASP3—epilepsy syndrome	4.81e-07	3.25e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—FGF2—epilepsy syndrome	4.8e-07	3.24e-06	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—AKT1—epilepsy syndrome	4.74e-07	3.2e-06	CbGpPWpGaD
Dasatinib—ERBB3—Disease—AKT1—epilepsy syndrome	4.74e-07	3.2e-06	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—AKT1—epilepsy syndrome	4.73e-07	3.19e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GPX1—epilepsy syndrome	4.72e-07	3.19e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—FGF2—epilepsy syndrome	4.72e-07	3.19e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ALB—epilepsy syndrome	4.7e-07	3.17e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—SRC—epilepsy syndrome	4.69e-07	3.17e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TSC2—epilepsy syndrome	4.68e-07	3.16e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AGT—epilepsy syndrome	4.68e-07	3.16e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—SRC—epilepsy syndrome	4.68e-07	3.16e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—JUN—epilepsy syndrome	4.67e-07	3.15e-06	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—AKT1—epilepsy syndrome	4.65e-07	3.14e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOE—epilepsy syndrome	4.58e-07	3.09e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—VEGFA—epilepsy syndrome	4.57e-07	3.08e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CASP3—epilepsy syndrome	4.55e-07	3.07e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.55e-07	3.07e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—RELA—epilepsy syndrome	4.55e-07	3.07e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—FGF2—epilepsy syndrome	4.55e-07	3.07e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP9—epilepsy syndrome	4.54e-07	3.07e-06	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—AKT1—epilepsy syndrome	4.54e-07	3.07e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	4.54e-07	3.06e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—MTOR—epilepsy syndrome	4.52e-07	3.05e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—epilepsy syndrome	4.52e-07	3.05e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—epilepsy syndrome	4.52e-07	3.05e-06	CbGpPWpGaD
Dasatinib—YES1—Immune System—AKT1—epilepsy syndrome	4.51e-07	3.04e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—KDR—epilepsy syndrome	4.49e-07	3.03e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—FGF2—epilepsy syndrome	4.49e-07	3.03e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—epilepsy syndrome	4.48e-07	3.02e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MTOR—epilepsy syndrome	4.46e-07	3.01e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—RELA—epilepsy syndrome	4.45e-07	3e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—POMC—epilepsy syndrome	4.45e-07	3e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—SRC—epilepsy syndrome	4.44e-07	2.99e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—JUN—epilepsy syndrome	4.42e-07	2.98e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AGT—epilepsy syndrome	4.38e-07	2.96e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—RELA—epilepsy syndrome	4.38e-07	2.96e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—JUN—epilepsy syndrome	4.38e-07	2.95e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MTOR—epilepsy syndrome	4.37e-07	2.95e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL2—epilepsy syndrome	4.35e-07	2.94e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PRKCB—epilepsy syndrome	4.32e-07	2.92e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	4.32e-07	2.91e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6ST—epilepsy syndrome	4.3e-07	2.9e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP9—epilepsy syndrome	4.3e-07	2.9e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—BCHE—epilepsy syndrome	4.3e-07	2.9e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MTOR—epilepsy syndrome	4.3e-07	2.9e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOE—epilepsy syndrome	4.3e-07	2.9e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.23e-07	2.85e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—RELA—epilepsy syndrome	4.22e-07	2.85e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—SRC—epilepsy syndrome	4.19e-07	2.83e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—AKT1—epilepsy syndrome	4.19e-07	2.83e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CAT—epilepsy syndrome	4.17e-07	2.82e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—RELA—epilepsy syndrome	4.17e-07	2.81e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AGT—epilepsy syndrome	4.14e-07	2.8e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MTOR—epilepsy syndrome	4.14e-07	2.79e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—epilepsy syndrome	4.11e-07	2.77e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	4.1e-07	2.77e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CASP3—epilepsy syndrome	4.1e-07	2.77e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—SRC—epilepsy syndrome	4.09e-07	2.76e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MTOR—epilepsy syndrome	4.09e-07	2.76e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—VEGFA—epilepsy syndrome	4.08e-07	2.75e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	4.06e-07	2.74e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOE—epilepsy syndrome	4.06e-07	2.74e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—TH—epilepsy syndrome	4.04e-07	2.73e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—AKT1—epilepsy syndrome	4.03e-07	2.72e-06	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—AKT1—epilepsy syndrome	4.02e-07	2.71e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CASP3—epilepsy syndrome	4.02e-07	2.71e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.01e-07	2.7e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—JUN—epilepsy syndrome	3.98e-07	2.69e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.98e-07	2.69e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—SRC—epilepsy syndrome	3.97e-07	2.68e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CASP3—epilepsy syndrome	3.95e-07	2.67e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—POMC—epilepsy syndrome	3.94e-07	2.66e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—FGF2—epilepsy syndrome	3.93e-07	2.65e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.9e-07	2.63e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—JUN—epilepsy syndrome	3.9e-07	2.63e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.88e-07	2.62e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP9—epilepsy syndrome	3.88e-07	2.62e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—VEGFA—epilepsy syndrome	3.86e-07	2.61e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL2—epilepsy syndrome	3.85e-07	2.6e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—JUN—epilepsy syndrome	3.84e-07	2.59e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—AKT1—epilepsy syndrome	3.81e-07	2.57e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CASP3—epilepsy syndrome	3.81e-07	2.57e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP9—epilepsy syndrome	3.79e-07	2.56e-06	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.79e-07	2.56e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.77e-07	2.55e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—AKT1—epilepsy syndrome	3.77e-07	2.54e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CASP3—epilepsy syndrome	3.76e-07	2.54e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—epilepsy syndrome	3.74e-07	2.52e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—AKT1—epilepsy syndrome	3.72e-07	2.51e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—JUN—epilepsy syndrome	3.7e-07	2.5e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—epilepsy syndrome	3.69e-07	2.49e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—JUN—epilepsy syndrome	3.65e-07	2.46e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—RELA—epilepsy syndrome	3.65e-07	2.46e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—epilepsy syndrome	3.6e-07	2.43e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MTOR—epilepsy syndrome	3.58e-07	2.41e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—SRC—epilepsy syndrome	3.57e-07	2.41e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—epilepsy syndrome	3.55e-07	2.4e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—AKT1—epilepsy syndrome	3.52e-07	2.38e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.5e-07	2.36e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—SRC—epilepsy syndrome	3.5e-07	2.36e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—epilepsy syndrome	3.49e-07	2.35e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—VEGFA—epilepsy syndrome	3.48e-07	2.35e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—FGF2—epilepsy syndrome	3.48e-07	2.35e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—AKT1—epilepsy syndrome	3.45e-07	2.33e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—SRC—epilepsy syndrome	3.44e-07	2.32e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—AKT1—epilepsy syndrome	3.44e-07	2.32e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—AKT1—epilepsy syndrome	3.43e-07	2.32e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—VEGFA—epilepsy syndrome	3.41e-07	2.3e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.38e-07	2.28e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—epilepsy syndrome	3.36e-07	2.27e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—AKT1—epilepsy syndrome	3.36e-07	2.27e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—VEGFA—epilepsy syndrome	3.35e-07	2.26e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—AKT1—epilepsy syndrome	3.35e-07	2.26e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.33e-07	2.25e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.33e-07	2.25e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—AKT1—epilepsy syndrome	3.32e-07	2.24e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.32e-07	2.24e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—SRC—epilepsy syndrome	3.32e-07	2.24e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—AKT1—epilepsy syndrome	3.31e-07	2.23e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AGT—epilepsy syndrome	3.31e-07	2.23e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CASP3—epilepsy syndrome	3.29e-07	2.22e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—SRC—epilepsy syndrome	3.27e-07	2.21e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOE—epilepsy syndrome	3.24e-07	2.19e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.24e-07	2.19e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—RELA—epilepsy syndrome	3.23e-07	2.18e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—VEGFA—epilepsy syndrome	3.23e-07	2.18e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—JUN—epilepsy syndrome	3.2e-07	2.16e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—VEGFA—epilepsy syndrome	3.19e-07	2.15e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—AKT1—epilepsy syndrome	3.19e-07	2.15e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—epilepsy syndrome	3.18e-07	2.14e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—AKT1—epilepsy syndrome	3.17e-07	2.14e-06	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—AKT1—epilepsy syndrome	3.17e-07	2.14e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MTOR—epilepsy syndrome	3.17e-07	2.14e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.17e-07	2.14e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—AKT1—epilepsy syndrome	3.15e-07	2.12e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.13e-07	2.11e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TH—epilepsy syndrome	3.12e-07	2.11e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—epilepsy syndrome	3.11e-07	2.1e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—AKT1—epilepsy syndrome	3.06e-07	2.06e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.01e-07	2.03e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	2.94e-07	1.99e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AKT1—epilepsy syndrome	2.92e-07	1.97e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CASP3—epilepsy syndrome	2.91e-07	1.97e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—AKT1—epilepsy syndrome	2.91e-07	1.96e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—SRC—epilepsy syndrome	2.87e-07	1.94e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—JUN—epilepsy syndrome	2.83e-07	1.91e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—VEGFA—epilepsy syndrome	2.79e-07	1.88e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—epilepsy syndrome	2.78e-07	1.88e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	2.78e-07	1.88e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—AKT1—epilepsy syndrome	2.76e-07	1.86e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—epilepsy syndrome	2.75e-07	1.86e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.64e-07	1.78e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.6e-07	1.76e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AKT1—epilepsy syndrome	2.6e-07	1.76e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.59e-07	1.75e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.57e-07	1.73e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—AKT1—epilepsy syndrome	2.54e-07	1.72e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—epilepsy syndrome	2.54e-07	1.71e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.5e-07	1.69e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—VEGFA—epilepsy syndrome	2.47e-07	1.67e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AKT1—epilepsy syndrome	2.46e-07	1.66e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—AKT1—epilepsy syndrome	2.44e-07	1.65e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.32e-07	1.57e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—AKT1—epilepsy syndrome	2.27e-07	1.53e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—AKT1—epilepsy syndrome	2.25e-07	1.52e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.22e-07	1.5e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.22e-07	1.5e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AKT1—epilepsy syndrome	2.22e-07	1.5e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AKT1—epilepsy syndrome	2.17e-07	1.47e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AKT1—epilepsy syndrome	2.14e-07	1.44e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—AKT1—epilepsy syndrome	2.06e-07	1.39e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AKT1—epilepsy syndrome	2.06e-07	1.39e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.04e-07	1.38e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AKT1—epilepsy syndrome	2.03e-07	1.37e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.03e-07	1.37e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOE—epilepsy syndrome	2e-07	1.35e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AKT1—epilepsy syndrome	1.78e-07	1.2e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.77e-07	1.2e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.72e-07	1.16e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AKT1—epilepsy syndrome	1.58e-07	1.06e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.56e-07	1.06e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.48e-07	9.98e-07	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AKT1—epilepsy syndrome	1.4e-07	9.43e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.37e-07	9.23e-07	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.12e-07	7.53e-07	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AKT1—epilepsy syndrome	8.91e-08	6.01e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.88e-08	4.64e-07	CbGpPWpGaD
